RE:RE:RE:RE:RE:Juvente + Scientific claims validated in a trial = BIG $Making my point. PGX is a delivery system with endless applications. As for cosmeceuticals and use in their Juvente line, it's going nowhere and until a partner comes in, time to shelve it as it's not going anywhere on its own.
prophetoffacts wrote: "When they were given the 360 Salon award by their industry peers in 2018 a lot of us were thinking Juvente could be a success. That was over 2 and a half years ago. Unless you can sell your better mouse trap, it's somewhat meaningless."
CZO won the 360 Salon award because of PGX. The award was a proof of principle. It demonstrated CZO could create an award winning PGX cosmeceutical. CZO still has to validate PGX at commercial scale. That is what it is doing now as it marches towards the commercial goal line with the immune booster. With commercial scale validation for PGX, and an award winning application like in cosmeceuticals the award has even more significance. CZO has demonstrated a number of proofs of principle for PGX from wound healing in a peer-review journal, to cosmeceuticals, to the functional drink. These proofs are important and increase in value as PGX is validated at commercial scale.